Pharmaceutical Companies and Their Suppliers Prepare for CPhI Worldwide - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Companies and Their Suppliers Prepare for CPhI Worldwide
A look at the happenings at this year's installment of CPhI Worldwide.



Fine-chemical companies, contract manufacturers, and pharmaceutical/biopharmaceutical companies will be assembling later this month at CPhI Worldwide, organized by UBM Live. The large exhibition featuring companies offering pharmaceutical ingredients and contract services will be held in Frankfurt, Oct. 22–24, with the exhibition starting on Tuesday Oct. 22 and the Pre-Connect Conference on Monday Oct. 21. The Pre-Connect conference will feature six modules covering six main topics: generics/supergenerics, drug delivery, biosimilars/biobetters, API sourcing in emerging markets, strategic partnering, and pharmaceutical packaging and labeling.

Three other shows will be co-located with CPhI. The International Contract Services Expo (ICSE) features exhibitors offering contract services in drug development and formulation services, finished product manufacturing, clinical research, and pharmaceutical software/information technology. P-MEC is focused on pharmaceutical machinery and equipment, and InnoPack includes exhibitors focused on packaging solutions. 

CPhI Worldwide and its co-located exhibitions are expected to attract 30,000 attendees from 140 countries and 2200 exhibitors. Last year's installment of CPhI Worldwide in Madrid attracted 30,413 attendees, which included both visitors and representatives from exhibiting companies. Attendees from Europe accounted for the largest number of attendees at approximately 60%, followed by attendees from Asia at nearly 24%, and attendees from North America at 7.5%. Among visitors, innovator pharmaceutical companies accounted for nearly 16% of the total and generic-drug companies 23%, according to information by ABC, an independent audit firm.

The CPhI Pharma Awards will be announced on Tuesday Oct. 22. The awards recognize innovation in three main categories: formulation, process development, and packaging. The award for innovation in formulation will recognize advances in drug delivery, excipients, controlled release, stability or bioavailability. Innovation in process development involves developments in synthesis, crystallization, polymorphism, catalysis or green chemistry. The award for innovation in packaging will recognize advances in primary packaging, devices and technology, patient compliance, dispensers, or materials.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here